FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:FAM35A-BMPR1A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: FAM35A-BMPR1A
FusionPDB ID: 29013
FusionGDB2.0 ID: 29013
HgeneTgene
Gene symbol

FAM35A

BMPR1A

Gene ID

54537

657

Gene nameshieldin complex subunit 2bone morphogenetic protein receptor type 1A
SynonymsFAM35A|FAM35A1|RINN2|bA163M19.110q23del|ACVRLK3|ALK3|CD292|SKR5
Cytomap

10q23.2

10q23.2

Type of geneprotein-codingprotein-coding
Descriptionshieldin complex subunit 2RINN1-REV7-interacting novel NHEJ regulator 2family with sequence similarity 35 member Aprotein FAM35Ashield complex subunit 2bone morphogenetic protein receptor type-1AALK-3BMP type-1A receptorBMPR-1Aactivin A receptor, type II-like kinase 3activin receptor-like kinase 3bone morphogenetic protein receptor, type IAserine/threonine-protein kinase receptor R5
Modification date2020031320200313
UniProtAcc.

P36894

Main function of 5'-partner protein: FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP2, BMP4, GDF5 and GDF6. Positively regulates chondrocyte differentiation through GDF5 interaction. Mediates induction of adipogenesis by GDF6. {ECO:0000250|UniProtKB:P36895}.
Ensembl transtripts involved in fusion geneENST idsENST00000298784, ENST00000298786, 
ENST00000480152, ENST00000372037, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 4 X 4=804 X 4 X 2=32
# samples 64
** MAII scorelog2(6/80*10)=-0.415037499278844
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/32*10)=0.321928094887362
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: FAM35A [Title/Abstract] AND BMPR1A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: FAM35A [Title/Abstract] AND BMPR1A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)FAM35A(88912636)-BMPR1A(88649819), # samples:2
BMPR1A(88635842)-FAM35A(88911107), # samples:1
Anticipated loss of major functional domain due to fusion event.FAM35A-BMPR1A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FAM35A-BMPR1A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FAM35A-BMPR1A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FAM35A-BMPR1A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFAM35A

GO:0045830

positive regulation of isotype switching

29656893

HgeneFAM35A

GO:2000042

negative regulation of double-strand break repair via homologous recombination

29656893

HgeneFAM35A

GO:2001034

positive regulation of double-strand break repair via nonhomologous end joining

29656893|29789392

TgeneBMPR1A

GO:0006468

protein phosphorylation

12065756

TgeneBMPR1A

GO:0010862

positive regulation of pathway-restricted SMAD protein phosphorylation

9389648|24904118

TgeneBMPR1A

GO:0030509

BMP signaling pathway

9389648|18436533

TgeneBMPR1A

GO:0060391

positive regulation of SMAD protein signal transduction

9389648



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:88912636/chr10:88649819)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across FAM35A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across BMPR1A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000298784FAM35Achr1088912636+ENST00000372037BMPR1Achr1088649819+12290163911431701018
ENST00000298786FAM35Achr1088912636+ENST00000372037BMPR1Achr1088649819+12290163911431701018

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000298784ENST00000372037FAM35Achr1088912636+BMPR1Achr1088649819+5.79E-050.99994206
ENST00000298786ENST00000372037FAM35Achr1088912636+BMPR1Achr1088649819+5.79E-050.99994206

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for FAM35A-BMPR1A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
FAM35Achr1088912636BMPR1Achr10886498191639508AFTVFLGDIILLTGQNLDSMLHGTGM

Top

Potential FusionNeoAntigen Information of FAM35A-BMPR1A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of FAM35A-BMPR1A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FAM35A-BMPR1A_88912636_88649819.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0101FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0101LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0101GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0102FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0102GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0102LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0105FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0105LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0105GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0107FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0107LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0107GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0111FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0111LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0111GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0111VFLGDIILLTGQNLD318
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0115FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0119FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0119LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0119GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0125FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0125LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0125GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0127FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0127LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0127GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0129FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0129LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0129GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0131FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0131LGDIILLTGQNLDSM520
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-0131GDIILLTGQNLDSML621
FAM35A-BMPR1Achr1088912636chr10886498191639DRB1-1521FLGDIILLTGQNLDS419
FAM35A-BMPR1Achr1088912636chr10886498191639DRB4-0101IILLTGQNLDSMLHG823
FAM35A-BMPR1Achr1088912636chr10886498191639DRB4-0103IILLTGQNLDSMLHG823
FAM35A-BMPR1Achr1088912636chr10886498191639DRB4-0106IILLTGQNLDSMLHG823
FAM35A-BMPR1Achr1088912636chr10886498191639DRB4-0107IILLTGQNLDSMLHG823
FAM35A-BMPR1Achr1088912636chr10886498191639DRB4-0108IILLTGQNLDSMLHG823

Top

Fusion breakpoint peptide structures of FAM35A-BMPR1A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FAM35A-BMPR1A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of FAM35A-BMPR1A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
FAM35A-BMPR1Achr1088912636chr1088649819318VFLGDIILLTGQNLDTGTTTCTTGGAGATATAATTTTACTCACAGGACAGAATCTGGATA
FAM35A-BMPR1Achr1088912636chr1088649819419FLGDIILLTGQNLDSTTCTTGGAGATATAATTTTACTCACAGGACAGAATCTGGATAGTA
FAM35A-BMPR1Achr1088912636chr1088649819520LGDIILLTGQNLDSMTTGGAGATATAATTTTACTCACAGGACAGAATCTGGATAGTATGC
FAM35A-BMPR1Achr1088912636chr1088649819621GDIILLTGQNLDSMLGAGATATAATTTTACTCACAGGACAGAATCTGGATAGTATGCTTC
FAM35A-BMPR1Achr1088912636chr1088649819823IILLTGQNLDSMLHGTAATTTTACTCACAGGACAGAATCTGGATAGTATGCTTCATGGCA

Top

Information of the samples that have these potential fusion neoantigens of FAM35A-BMPR1A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for FAM35A-BMPR1A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneBMPR1Achr10:88912636chr10:88649819ENST00000372037213153_1760533.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to FAM35A-BMPR1A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to FAM35A-BMPR1A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource